International Clinical Psychopharmacology

Current Issue

November 2023 - Volume 38 - Issue 6

Editor-in-Chief: Alessandro Serretti
ISSN: 0268-1315
Online ISSN: 1473-5857
Frequency: 6 issues / year
Ranking: 108 of 155 Psychiatry
184 of 277 Pharmacology & Pharmacy
Impact Factor: 2.6

Current Issue Highlights

Editorial

The interplay of psychopharmacology and medical conditions

Serretti, Alessandro

International Clinical Psychopharmacology. 38(6):365-368, November 2023.

PDF
Permissions

Buy

Original Articles

Valbenazine for tardive dyskinesia: a systematic review and network meta-analysis

Kishi, Taro; Sakuma, Kenji; Iwata, Nakao

International Clinical Psychopharmacology. 38(6):369-374, November 2023.

Buy

Navigating the pharmacologic complexities of QTc prolongation: assessing the cumulative burden in individuals with serious mental illness

Demler, Tammie Lee; O’Donnell, Carolyn

International Clinical Psychopharmacology. 38(6):375-383, November 2023.

Buy

Case Report

Neuropsychiatric symptoms in a patient under cystic fibrosis transmembrane conductance regulator modulators treatment: a case report

Andreu, Helena; Olivier, Luis; Giménez-Palomo, Anna; More

International Clinical Psychopharmacology. 38(6):402-405, November 2023.

Buy

Commentary

Severe methodological problems in a recent review and analysis of the association between lithium concentration in potable water and suicide rates

Plöderl, Martin; Naudet, Florian

International Clinical Psychopharmacology. 38(6):406-407, November 2023.

PDF
Permissions

Buy

Journal Statistics

Acceptance rate: 60%

Average time for first decision: 6 weeks (excluding articles declined immediately in less than 1 week).

Average time to final decision for accepted articles: 7 weeks (excluding time for revision)

Click on the link below to submit your manuscript to International Clinical Psychopharmacology.

Featured Jobs

COVID-19 Resources

Access FREE essential Coronavirus Resources UpToDate® plus Ovid® Expert Search tools.

Provided by Wolters Kluwer